Join us for a quick overview of Novo Nordisk A/S, a Pharmaceutical company ... The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart ...

PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...

Novo Nordisk shares rose by more than 5% after the Danish weight-loss drug maker said the Food and Drug Administration accepted a new drug application for a pill form of its popular Wegovy injection.

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

LONDON (Reuters) -The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in ...

Eli Lilly on Thursday posted better-than-expected quarterly results, although sales of its popular weight-loss drug, Zepbound ...